Changes in the levels of integrin and focal adhesion kinase (FAK) in human melanoma cells following 532 nm laser treatment

International Journal of Cancer

Volumn 82, Issue 3, 1999, Pages 353-358

  Zhu, Ning Wen ^a,b   Perks, Claire M ^a   Burd, Andrew R ^b   Holly, Jeff M P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; INTEGRIN; INTEGRIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LASER; MELANOMA CELL; NEODYMIUM LASER; PRIORITY JOURNAL;

CELL ADHESION MOLECULES; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRINS; LASERS; MELANOMA; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED;

EID: 0344848631     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990730)82:3<353::AID-IJC8>3.0.CO;2-4     Document Type: Article

References (29)

1. FAK) expression correlates with motility of human melanoma cell lines. J. invest. Dermatol., 105, 104-108 (1995).
2. BOCKHOLT, S.M. and BURRIDGE, K., Cell spreading on extracellular matrix proteins induces tyrosine phosphorylation of tensin. J. biol. Chem., 268, 565-567 (1993).
3. BURRIDGE, K., FATH, K., KELLY, T., NUCKOLLS, G. and TURNER, C., Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Ann. Rev. Cell Biol., 4, 487-525 (1988).
4. BURRIDGE, K., TURNER. C.E. and ROMER, L.H., Tyrosine phosphorylation of paxillin pp125 FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell Biol., 119, 893-903 (1992).
5. FREEDMAN, V.H. and SHIN, S., Cellular tumorigenicity in nude mice: correlation with cell growth in semisolid medium. Cell. 3, 353-359 (1974).
6. GARI, L.M., RIVERS, J.K. and KOPF, A.W., Melanomas arising in large congenital naevocytic naevi: a prospective study. Pediatr. Dermatol., 5, 151-158 (1988).
7. FAK both by cellular adhesion and by oncogenic transformation. Nature (Lond.), 358, 690-692 (1992).
8. GUAN, J.L., TREVITHICK, J.E. and HYNES, R.O., Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul., 2, 951-964 (1991).
9. HYNES, R.O., Integrins: versatility, modulation and signalling in cell adhesion. Cell, 69, 11-25 (1992).
10. ILLIC, D., FURUTA, Y., KANAZAWA, S., TAKEDA, N., SOBUE, K., NAKATSUJI, N., NOMURA, S., FUJIMOTO, T., OKADA, M., YAMAMOTO, T. and AIZAWA, S., Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (Lond.), 377, 539-544 (1995).
11. KOPF, A.W., LEVINE, L.J., RIGEL, D.S., FRIEDMAN, R.J. and LEVENSTEIN, M., Congenital-naevus-like naevi, naevi spili, and cafe-au-lait spots in patients with malignant melanoma. J. Dermatol. surg. Oncol., 11, 275-280 (1985).
12. KORNBERG, L.J., EARP, H.S., TURNER, C.E., PROCKOP, C. and JULIANO, R.L., Signal transduction by integrins: increased protein tyrosine phosphorylation caused by integrin clustering. Proc. nat. Acad. Sci. (Wash.), 88, 8392-8396 (1991).
13. FAK in platelets. J. Cell Biol., 119, 905-912 (1992).
14. MARSHALL, J.F., RUTHERFORD, D.C., HAPPERFIELD, L., HANBY, A., MCCARTNEY, A.C.E., NEWTON-BISHOP, J. and HART, I., Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas. Brit. J. Cancer, 77, 522-529 (1998).
15. MASON, M.D., ALLMAN, R. and QUIBELL, M., Adhesion molecules in melanoma - more than just superglue. J. roy. Soc. Med., 89, 393-395 (1996).
16. NATALI, P.G., NICOTRA, M.R., BARTOLAZZI, A., CAVALIERE, R. and BIGOTTI, A., Integrin expression in cutaneous malignant melanoma: association of the a3b1 heterodimer with tumour progression. Int. J. Cancer, 54, 68-72 (1993).
17. OWENS, L.V., HU, L., CRAVEN, R.J., DENT, G.A., WEINER, T.M., KORNBERG, L., LIU, E.T. and CANCE, W.G., Overexpression of focal adhesion kinase (p125FAK) in invasive human tumours. Cancer Res., 55, 2752-2755 (1995).
18. PANKOVICH, J.M. and JIMBOW, K., Tyrosine transport in a human melanoma cell line as a basis for selective transport of cytotoxic analogues. Biochem. J., 280, 721-725 (1991).
19. RANKIN, S. and ROZENGURT, E., Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. J. biol. Chem., 269, 704-710 (1994).
20. REICHARD BROWN, J.L. and AKESON, R., Correlation of the cell phenotype of cultured cell lines with their adhesion to components of the extracellular matrix. Develop. Biol., 96, 304-316 (1983).
21. RHODES, A.R. and MELSKI, J.W., Small congenital naevocellular naevi and the risk of cutaneous melanoma. J. Pediatr., 100, 219-224 (1982).
22. RUOSLAHTI, E. and PIERSCHBACHER, M.D., New perspectives in cell adhesion. Science, 238, 491-497 (1987).
23. SCHADENDORF, D., GAWLIK, C., HANEY, U., OSTMEIER, H., SUTER, L. and CZARNETZKI, B.M., Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J. Pathol., 170, 429-434 (1993).
24. STUIVER, I. and O'TOOLE, T.E., Regulation of integrin function and cellular adhesion. Stem Cells, 13, 250-262 (1995).
25. TUCKER, R.W., BUTTERFIELD, C.E. and FOLKMAN, J., Interaction of serum and cell spreading affects growth of neoplastic and nonneoplastic cells. J. supramol. Struct., 15, 29-40 (1981).
26. YOSHINAGA, I.G., VINK, J., DEKKER, S.K., MIHM, M.C. JR. and BYERS, H.R., Role of alpha3, beta1 and alpha2 beta1 integrins in melanoma cell migration. Melanoma Res., 3, 435-441 (1993).
27. FAK): a point of convergence in the action of neuropeptides, integrins and oncogenes. Cell, 71, 891-894 (1992).
28. ZACHARY, I., SINNETT-SMITH, J. and ROZENGURT, E., Bombesin, vasopressin and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. J. biol. Chem., 267, 19,031-19,034 (1992).
29. ZHU, N.W., KENEALY, J., BURD, A., GRADIDGE, T., WARR, R., RIGBY, H.S. and KEMSHEAD, J.T., Sub-lethal effects of exposing the human melanoma cell line Skmel-23 to 532 nm laser light. Int. J. Cancer, 72, 1104-1112 (1997).